136 related articles for article (PubMed ID: 23128569)
1. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.
Thanasupawat T; Hammje K; Adham I; Ghia JE; Del Bigio MR; Krcek J; Hoang-Vu C; Klonisch T; Hombach-Klonisch S
Oncol Rep; 2013 Jan; 29(1):149-54. PubMed ID: 23128569
[TBL] [Abstract][Full Text] [Related]
2. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors.
Mashima H; Ohno H; Yamada Y; Sakai T; Ohnishi H
Biochem Biophys Res Commun; 2013 Mar; 432(4):586-92. PubMed ID: 23438439
[TBL] [Abstract][Full Text] [Related]
3. Expression of the relaxin family peptide 4 receptor by enterochromaffin cells of the mouse large intestine.
Koo A; Pustovit RV; Woodward ORM; Lewis JE; Gribble FM; Hossain MA; Reimann F; Furness JB
Cell Tissue Res; 2022 Jul; 389(1):1-9. PubMed ID: 35596811
[TBL] [Abstract][Full Text] [Related]
4. INSL5 activates multiple signalling pathways and regulates GLP-1 secretion in NCI-H716 cells.
Ang SY; Evans BA; Poole DP; Bron R; DiCello JJ; Bathgate RAD; Kocan M; Hutchinson DS; Summers RJ
J Mol Endocrinol; 2018 Apr; 60(3):213-224. PubMed ID: 29535183
[TBL] [Abstract][Full Text] [Related]
5. Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation.
Belgi A; Hossain MA; Shabanpoor F; Chan L; Zhang S; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2011 Oct; 50(39):8352-61. PubMed ID: 21866895
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
[TBL] [Abstract][Full Text] [Related]
7. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
8. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
9. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
10. Reviewing the physiological roles of the novel hormone-receptor pair INSL5-RXFP4: a protective energy sensor?
Hechter D; Vahkal B; Tiede T; Good SV
J Mol Endocrinol; 2022 May; 69(1):R45-R62. PubMed ID: 35521762
[TBL] [Abstract][Full Text] [Related]
11. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.
Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA
Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of relaxin family peptide receptor 4 in human spermatozoa and impact of insulin-like peptide 5 on sperm functions.
Yeganeh IS; Taromchi AH; Fathabadi FF; Nejatbakhsh R; Novin MG; Shokri S
Reprod Biol; 2017 Dec; 17(4):327-332. PubMed ID: 28986276
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like peptide 5 is an orexigenic gastrointestinal hormone.
Grosse J; Heffron H; Burling K; Akhter Hossain M; Habib AM; Rogers GJ; Richards P; Larder R; Rimmington D; Adriaenssens AA; Parton L; Powell J; Binda M; Colledge WH; Doran J; Toyoda Y; Wade JD; Aparicio S; Carlton MB; Coll AP; Reimann F; O'Rahilly S; Gribble FM
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11133-8. PubMed ID: 25028498
[TBL] [Abstract][Full Text] [Related]
14. Colokinetic effect of an insulin-like peptide 5-related agonist of the RXFP4 receptor.
Diwakarla S; Bathgate RAD; Zhang X; Hossain MA; Furness JB
Neurogastroenterol Motil; 2020 May; 32(5):e13796. PubMed ID: 31989750
[TBL] [Abstract][Full Text] [Related]
15. Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4.
Hu MJ; Wei D; Shao XX; Wang JH; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2017 Apr; 619():27-34. PubMed ID: 28274616
[TBL] [Abstract][Full Text] [Related]
16. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
17. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
18. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility.
Burnicka-Turek O; Mohamed BA; Shirneshan K; Thanasupawat T; Hombach-Klonisch S; Klonisch T; Adham IM
Endocrinology; 2012 Oct; 153(10):4655-65. PubMed ID: 22822165
[TBL] [Abstract][Full Text] [Related]
19. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
20. Single cell transcriptomic profiling of large intestinal enteroendocrine cells in mice - Identification of selective stimuli for insulin-like peptide-5 and glucagon-like peptide-1 co-expressing cells.
Billing LJ; Larraufie P; Lewis J; Leiter A; Li J; Lam B; Yeo GS; Goldspink DA; Kay RG; Gribble FM; Reimann F
Mol Metab; 2019 Nov; 29():158-169. PubMed ID: 31668387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
